Unidym Enters into Joint Development Agreement with Major LCD Manufacturer

Unidym, Inc, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), announced today that it has entered into a joint development agreement with a major liquid crystal display (LCD) manufacturer. Under the agreement, Unidym will work with the Process Development Group at the major liquid crystal display (LCD) manufacturer to integrate CNT transparent conductive films into glass-based liquid crystal displays.

Under the new agreement, Unidym will focus on depositing its CNT inks on color filter glass and the thin film transistor backplane for rigid displays. The primary advantages of Unidym’s products in glass-based liquid crystal displays are lower cost of materials and deposition, increased yield, and elimination of the acid patterning process associated with ITO.

Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is seeking to build value for shareholders through the progress of majority owned subsidiaries and minority investments commercializing nanotech products and applications.

Unidym is a leader in carbon nanotube-based transparent, conductive films (TCFs) for the electronics industry. TCFs are a critical component in devices such as touch panels, displays, and thin-film solar cells. For example, both touch panels and LCDs typically employ two TCF layers per device. Unidym's TCFs offer substantial advantages over the incumbent technology, indium-based metal oxides, including: improved durability, lower processing costs, and lower overall cost structure.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.